1)TOPO ⅡTOPOⅡ
1.Objective To investigate the expressions of multidrug resistance related genes(P gp, GST π and TOPO Ⅱ) in primary hepatocellular carcinoma (PHC).目的 探讨肝癌组织中 ,多项耐药相关基因 (P gp、GST π ,TOPOⅡ )的表达水平及其临床意义。
英文短句/例句
1.The Study of Combination of Topoisomerase Ⅰ Inhibitor and Topoisomerase Ⅱ Inhibitor;TOPOⅠ与TOPOⅡ抑制剂联合应用的研究
2.Expression of Topo Ⅱ and its clinical implication in nasopharyngeal carcinoma鼻咽癌组织中TOPOⅡ的表达及临床意义
3.Expression and Clinical Significance of P-gp、TOPOⅡ、GST-π and LRP in Breast Cancer;P-gp、TOPOⅡ、GST-π、LRP乳腺癌中的表达及临床意义
4.Expression and clinical significance of lung resistance protein,topoisomeraseⅡ and glutathione-S-transferase-π in non-small cell lung cancerLRP、TOPOⅡ及GSTπ-在非小细胞肺癌中的表达及临床意义
5.The Expression and Significance of P-glycoprotein, Lung Resistance Associated Protein, and Topoismerase Ⅱ in Cells of Hypopharyngeal Carcinoma Induced by 5-fluorouracil喉咽癌细胞5-氟尿嘧啶耐药筛选前后P-170、LRP、TOPOⅡ的表达及意义
6.Significance of P-glucoprotein,glutathione S-transferase π ,topoisomerase Ⅱ,expression in nodal peripheral T-cell lymphamaP-gp170、GST-π、TOPOⅡ在外周T细胞淋巴瘤中的表达及意义
7.Expression and clinical significance of GST-π、TopoⅡ in salivary gland neoplasmGST-π、TopoⅡ在涎腺肿瘤中的表达及意义
8.Expression and Clinical Significance of P-gp,GST-π,Topo Ⅱ and LRP in Gastric Carcinoma;P-gp、TopoⅡ、GST-π、LRP在胃癌中的表达及临床意义
9.The Expression and Significance of P-gp, TopoⅡ and GST-π in Colorectal Carcinoma;P-gp、TopoⅡ、GST-π在结直肠癌中的表达及意义研究
10.Expression and Relationship between DNA TopoⅡ and CD44v6 in Gastric Carcinoma;DNA TopoⅡ和CD44v6在胃癌组织中的表达及其相关性研究
11.Effect of ephedrine on the expression of MDR1、MRP、TopoⅡand GST in K562/A02 Cells麻黄碱对K562/A02细胞MDR1、MRP、TopoⅡ和GST表达的影响
12.The expressions of nm23,Ki-67 and ToPoⅡ in gastrointestinal adenocarcinoma胃肠道腺癌组织中nm23与Ki-67、ToPoⅡ的表达情况分析
13.The Role of Transcription Factor NF-Y and Sp1 in Cisplatin Up-regulating the Expression of TopoⅡ in Ovarian Cancer Cell Line SKOV3;NF-Y和Sp1在顺铂上调卵巢癌细胞topoⅡ表达中的作用
14.Expression of Epidermal Growth Factor Receptor (EGFR) P-glycoprotein (P170), Topoisomerase Ⅱ (ToPo Ⅱ) and Glutathione S-transferase π(GST-π) in Gastric Carcinoma and Their Correlations with Clinical Prognosis;EGFR、ToPoⅡ、P170、GST-π蛋白在胃癌中表达与临床关系的研究
15.Expression of P-gp GST-π and Topo Ⅱ in the Malignant Tumor of Biliary Tract and Its Clinical SignificanceP-gp、GST-π、TopoⅡ在胆道恶性肿瘤中的表达与临床意义
16.Chemosensitivity of Primary Cultured Human Breast Cancer Cells in Vitro and Its Expression of Her-2 and TopoⅡ人乳腺癌细胞原代培养体外药敏试验及Her-2、TopoⅡ的表达
17.Expression and clinical significance of multidrug resistance gene LRP,GST-π and Topo Ⅱ in colorectal carcinoma多药耐药基因产物LRP、GST-π、TopoⅡ在大肠癌中的表达及临床意义
18.Role of 16-Slice Spiral CT and TopoⅡ Assay in Preoperative Staging for Rectal Carcinoma16层螺旋CT及TopoⅡ表达分析在直肠癌术前分期中的价值
相关短句/例句
topoisomeraseⅡTopoⅡ
1.Objectives:The purpose of this study is to investigate the effects of Angelicasinensis(Oliv)Diels compound injection, Ephedrine, Vauqueline and Strychnine on human leukemic multidrug resistance(MDR) in K562/A02 cell line MDR1(multidrug resistance 1), MRP(multidrug resistance-associated protein), TopoⅡ(topoisomeraseⅡ), GST-π(glutathione s-transferase) genes and their proteins.目的:通过研究中药复方当归注射液(Angelicasinensis(Oliv)Diels compound injection)、麻黄碱(Ephedrine)、马钱子碱(Vauqueline)、士的宁(Strychnine)对人白血病多药耐药细胞株K562/A02 MDR1(multidrug resistance 1)、MRP(multidrug resistance-associated protein)、TopoⅡ(topoisomeraseⅡ)、GST-π(glutathione s-transferase)基因及其蛋白表达的影响,探讨上述四种中药对K562/A02细胞多药耐药的逆转途径。
3)topo II inhibitorsTopoⅡ抑制剂
4)TopoisomeraseⅡ(ToPoⅡ)拓扑异构酶Ⅱ(TopoⅡ)
5)topoisomerase Ⅱ(TOPOⅡ)拓扑异构酶(TOPOⅡ)
延伸阅读
TOPO分子式:C24H51OP分子量:386.64006CAS号:78-50-2性质:暂无制备方法:暂无用途:暂无
